Sphenopalatine Ganglion Stimulation – Proof-of-Concept in the Treatment of Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorhage

Sphenopalatine Ganglion Stimulation – Proof-of-Concept in the Treatment of Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorhage - SPG Vasospasm

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027984

Enrollment

Registered

2022-02-03

Start date

2022-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I67.8

Interventions

Group 1: Sphenopalatine ganglion stimulation for 24h

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aneurysmatic subarachnoidal bleeding 2. Vasospasm needing treatment

Exclusion criteria

Exclusion criteria: 1. Children and adolescents

Design outcomes

Primary

Measure	Time frame
Changes in brain perfusion on CT perfusion	—

Secondary

Measure	Time frame
Changes in brain perfusion on CT perfusion and transcranial doppler, short-term neurological outcomes, cerebral oxygen saturation	—

Countries

Germany

Contacts

Public ContactGuilherme Santos Piedade

Universitätsklinikum Düsseldorf

guilherme.santospiedade@med.uni-duesseldorf.de02118116058

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026